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Abstract: Hybrid foam (BG-PVA) with 50 % Bioactive glass (BG) and 50 % polyvinyl alcohol (PVA) was prepared by 
sol-gel process to produce scaffolds for bone tissue engineering. The pore structure of hydrated foams was evaluated by 3-
D confocal microscopy, confirming 70% porosity and interconnected macroporous network. In this study, we assessed the 
putative advantage of coating with osteostatin pentapeptide into BG-PVA hybrid scaffolds to improve their bioactivity. In 
vitro cell culture experiments were performed using mouse pre-osteoblastic MC3T3-E1 cell line. The exposure to 
osteostatin loaded-BG-PVA scaffolds increase cell proliferation in contrast with the unloaded scaffolds. An in vivo study 
was selected to implant BG-PVA scaffolds, non-coated (Group A) or coated (Group B) with osteostatin into non critical 
bone defect at rabbit femur. Both groups showed new compact bone formation on implant surface, with lamellae disposed 
around a haversian canal forming osteons-like structure. We observed signs of inflammation around the implanted 
unloaded scaffold at one month, but resolved at 3 months. This early inflammation did not occur in Group B; supporting 
the notion that osteostatin may act as anti-inflammatory inhibitor. On the other hand, Group B showed increased bone 
formation, as depicted by many new trabeculae partly mineralized in the implant regenerating area, incipient at 1 month 
and more evident at 3 months after implantation. PVA/BG hybrid scaffolds present a porous structure suitable to support 
osteoblast proliferation and differentiation. Our in vitro and in vivo findings indicate that osteostatin coating improves the 
osteogenic features of these scaffolds 
Keywords: Bioactive glass, bone regeneration, femur bone lesion, hybrid matrix, polyvinyl alcohol. 
INTRODUCTION 
 High rates of fractures worldwide have motivated the 
development of strategies to promote damaged bone tissue 
repair. The use of bone allograft materials arose due to the  
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limited amount of autologous bone available for implants. 
Human bone implants could prevent a putative antigenic host 
response, although they increase the risk of infection before 
and after surgery [1, 2]. A tissue engineering strategy 
involves the use of a scaffold as a three-dimensional 
template to guide bone repair. Ideally, this scaffold will give 
support to cells and/or osteogenic agents to help stimulate 
the natural bone regenerative mechanisms. These techno-
logies have evolved in the last years towards the develop-
ment of optimal tissue substitutes based on a better under-
standing of structure-function relations in normal and 
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diseased tissue. Using this approach, smart biomaterials have 
been developed, which can promote the reestablishment of 
lost tissue function as a result of trauma [3-6]. An ideal 
scaffold for bone regeneration must display osteoconduc-
tivity and osteoinductivity features, and it would also be able 
to support load inputs when implanted in bone [7]. Such 
scaffold would consist of a biomaterial with an inter 
connected porous network structure and its shape should be 
adapted to fill a particular defect [8, 9].  
 The development of inorganic-organic composites 
attempts to create a balance between strength and toughness, 
in turn improving the characteristics commonly found in the 
individual components of the composite. These composites 
can be synthesized through a hybridization route, combining 
two or more organic and inorganic components [10-15]. Sol-
gel technology allows for the incorporation of different types 
of polymers within an inorganic silica bulk, thus producing 
organic-inorganic hybrid materials. The bioactive inorganic 
and polymer components of these scaffolds should 
biodegrade over time, allowing bone to remodel naturally, 
without a toxic response caused by the degradation products 
[12, 15]. Also, orgaic-inorganic hybrids has been recognized 
as a strategy to improve the mechanical behavior of 
biosactive glass-based materials. 
 In this regard, bioactive glass (BG)-polymer hybrids are 
promising materials for biomedical applications because they 
combine BG bioactivity and the flexibility of polymers. In a 
previous study, hybrid foams with 50% BG and 50% 
polyvinyl alcohol (PVA) were prepared by the sol-gel 
process for application as scaffolds in bone tissue 
engineering. The surfactant-aided foaming process produces 
interconnected macroporous, and a nanoporous texture is 
inherent to the sol–gel process. The foams support 
compressive strengths of 0.60 MPa with a modal 
interconnect diameter of 250 µm between the larger 
spherical pores (diameter in the range of 100-500 µm, 68 % 
porosity). These types of foams have structural 
characteristics that comply with the aforementioned 
surgeon’s criteria. In vitro studies showed that osteoblastic 
cells maintained their viability in cultures containing these 
hybrid foams [15].  
 A suitable approach in bone tissue engineering consists 
of decorating a biomaterial scaffold with osteogenic agents 
in order to promote the repair process. In this respect, we 
recently coated several Si-doped ordered mesoporous 
ceramics with a parathyroid hormone-related protein 
(PTHrP)-derived peptide, PTHrP (107-111) (TRSAW, 
osteostatin) [16-18]. Immobilized osteostatin by covalent 
binding to the surface of these materials was similarly 
bioactive as the freely diffusible peptide when tested in 
osteoblastic cell cultures [17, 18]. This pentapeptide 
conferred osteogenic properties to these ceramics when 
implanted into a cavitary defect in rabbits [19, 20]. These 
findings suggest that osteostatin can be a bone regenerating 
factor.  
 In the present study, we assessed the putative advantage 
of coating the osteostatin pentapeptide into BG-PVA hybrid 
scaffolds for improving their bioactivity. To this aim, we 
used an in vitro approach in osteoblastic cell cultures and an 
in vivo model by implanting these scaffolds in a non critical 
bone defect in rabbits. 
MATERIALS AND METHODS 
Hybrid BG-PVA Matrix Synthesis 
 The reagents used to synthesize the materials were: 
tetraethyl orthosilicate (TEOS) (Sigma-Aldrich, Saint Louis, 
USA), hydrofluoric acid (HF) 80 % hydrolyzed (Merck, 
Darmstadt, Germany), PVA (Sigma-Aldrich, St. Louis, 
MO); and surfactant sodium lauryl ether sulfate (Sulfal, Belo 
Horizonte, Brazil). The hybrids with an inorganic phase 
composition of 35 % SiO2-15 % CaO and 50 % PVA as 
organic fraction were prepared by the acid hydrolysis of 
TEOS followed by the addition of calcium chloride (Vetec, 
São Paulo, Brazil) and 20 % PVA solution. Twenty seven % 
of the surfactant solution and 48 % HF were then added, 
mixture was vigorously stirred to form the foam, which was 
then cast in a container were it gelled, and was dried at 40 ºC 
in an air circulation oven for one week. Hybrids produced by 
this method had a highly acidic character conferred by the 
catalysts added during the process. Thus, an additional 
neutralization step was necessary to produce biocompatible 
foams: samples were immersed three times, 30 minutes each, 
in aqueous-alcoholic calcium acetate solution (0.5M). After 
neutralization, the materials were dried again at 40 ºC in an 
air circulation oven for one week and under high vacuum for 
48 h [6, 15, 21]. 
Scanning Electron Microscopy (SEM) and Energy 
Dispersive X-ray Spectroscopy (EDS) 
 SEM images were taken from organic–inorganic hybrids 
with a Jeol scanning electron microscope equuiped with EDS 
spectrometer apparatus (JSM 6360V, JEOL/Noran, Japan). 
SEM photomicrographs were used for the evaluation of 
hybrid foam microstructure. Prior to SEM examination, 
samples were coated with a thin gold film by sputtering. 
Images of secondary electrons (SE) were obtained using an 
accelerating voltage of 10-15 kV. Images were acquired with 
two different magnifications (100 and 200x). 
Confocal Microscopy 
 A Nikon eclipse TE2000-E inverted microscope, D-
eclipse C1si scan head, (Nikon Instruments Inc., Melville, 
New York) was used. Materials were stained with 
fluorescein and excited at 488 nm with an argon laser. 
Fluorescence was detected at 515 nm using a 35 bandwidth 
filter. Serial optical sections in the z axis were captured by 
laser scanning confocal microscopy with a resolution of 1.25 
um at 512x512 pixels, with a Plan Apo 20x objective 0.75 
N.A (numerical aperture of the objective). Z-stacks were 
rebuilt on 3D representation with Nikon C1 software. 
Preparation of PVA/BG Scaffolds with Adsorbed 
Osteostatin 
 Hybrid scaffolds 50% PVA/50% (% m/m) GB BG were 
loaded with synthetic osteostatin (Bachem, Bubendorf, 
Switzerland) by soaking them in a solution of each peptide 
(at 100 nM) in 1 ml of phosphate-buffered saline, pH 7.4 
(PBS) at 4 ºC under stirring for 24 h. Peptide release was 
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assessed by either measuring absorbance at 280 nm or 
including a radiotracer based on an osteostatin-extended 
sequence, 
125
I [Tyr
116
]TRSAWBzFSTAAYGLLE (20,000 
cpm) together with non-radiolabeled osteostatin during 
loading, as described elsewhere [16, 17]. In the latter case, 
the released radioactivity into the incubation medium was 
sequentially monitored for several hours by counting in a γ-
spectrometer.  
Cell Culture Studies 
 Cell culture experiments were performed using the well 
characterized mouse pre-osteoblastic MC3T3-E1 cell line 
[16, 17, 22]. Tested scaffolds were placed into each well of 
6- or 24-well plates before cell seeding. Then, MC3T3-E1 
cells were plated at a density of 10,000 cells/cm
2
 in 2 ml of 
α-minimum essential medium containing 10% fetal bovine 
serum, 50 µg/ml ascorbic acid, 10 mM ß-glycerol-2-
phosphate and 1% penicillin–streptomycin at 37 ºC in 5% 
CO2, and incubated for different times. Some wells 
contained no scaffolds as controls. Cell proliferation was 
determined by addition of Alamar Blue solution (AbD 
Serotec, Oxford, UK) at 10% (v/v) to the cell culture at day 
4. Four hours after, 1-ml samples of the cell-conditioned 
medium were added to 24-well plates, and fluorescence 
intensity was measured using excitation emission 
wavelengths of 540 and 620 nm, respectively. In addition, 
following incubations with the scaffolds for 4 days, cells 
were washed with PBS, and alkaline phosphatase (ALP) 
activity was measured in cell extracts obtained with 0.1% 
Triton X-100 using p-nitrophenylphosphate as substrate, as 
described previously [16, 17, 22]. ALP activity was 
normalized to cell protein content, determined by the BCA 
(bicinchoninic acid) (Thermo Scientific, Rockford, IL, USA) 
method with bovine serum albumin as standard. Matrix 
mineralization was measured by alizarin red staining after 
cell incubation with the tested materials for 10 days, as 
described [16, 17, 22]. Stain was dissolved with 10% 
cetylpyridinum chloride in 10 mM sodium phosphate, pH 7, 
and measuring absorbance at 620 nm. 
In vivo Bone Hybrid Matrix Implantation With and 
Without Immobilized Osteostatin in a Non Critical Bone 
Defect in Rabbit 
 Three-month old female New Zealand rabbits (n=12), 
kept in individual cages with food and water ad libitum, were 
used. Animals were randomly subdivided in two groups, and 
assigned to receive an unloaded (Group A) or osteostatin-
loaded (Group B) matrix implant (n=6 for each group), as 
described. Our protocol used a limited number of rabbits and 
was approved by the Bioethic Committee of our Institutions. 
Regulations adhere to the well established guidelines for 
animal care and manipulation to decrease pain and suffering 
of the animal. 
 Antibiotic prophylaxis with cefazolin (50 mg/kg/day, 
intramuscularly) was carried out 2 days prior to the surgical 
procedure, as described [2]. Thereafter, the rabbits were 
anaesthesized by administering a mixture of ketamine 
hydrochloride (35 mg/kg)/ 2% xylazine hydrochloride  
(18mg/kg)/ 1% acepromazine maleate (1mg/kg), 
subcutaneously, which produced complete relaxation of the 
animals within 45-60 min (surgical procedure period). Then, 
a cutaneous longitudinal 4-cm incision was performed in the 
shaven distal femoral epiphysis. Both, medial and lateral 
flaps were divided and an opening of a non muscular 
aponeurotic plane was made until reaching the bone area of 
interest. The cavitary defect was then created (6 mm 
diameter and 3 mm deep) by a bit set up to a sterile electrical 
motor. After washing the bone defect with sterile saline and 
hemostasis of the lesion with a sterile swab plus gauze, the 
tested scaffolds, previously rehydrated in the own animal’s 
blood, were implanted and the wounds were sutured. During 
the period of study (up to three months post-implantation), 
animals were clinically monitored, body temperature was 
measured daily during the first week, and then weekly. 
Biochemical serological parameters (blood cell counts, 
erythrocyte sedimentation rate, blood glucose, uremia and 
total serum proteins) were evaluated by standard procedures 
at days 3 and 11 and at the end of the study. At 1 and 3 
months after implantation, 3 rabbits of each group studied 
removing femora under general anaesthesia, and assigned to 
histological analysis. 
Bone Histology 
 Femoral bone samples were submitted to radiographic 
study using a conventional dental X-ray machine with dental 
occlusal films (Eastman Kodak Company, Rochester, NY, 
USA) to determine the implant position to guide the 
histological procedures. Femoral epiphysis was cut 2 cm 
below the metaphysis with a carborundum-disk cutter 
(Dochem, Shanghai, China) using a dental drill. The 
implanted area was marked by indian ink. Bone specimens 
were dehydrated in acetone and embedded in methyl 
methacrylate. For each specimen, 2–5 series of consecutive 
sections (7-μm thick) were cut (at least 150 μm apart) with a 
manual rotative microtome (Micron-Zeiss, Germany), placed 
on Haupt´s adhesive coated slides, and left to dry at 50°C for 
18 h. The sections were deplastified with ethylene glycol 
mono ethyl acetate for optimal staining with either toluidine 
blue (pH 3.7) or Goldner Trichrome. Photomicrographs were 
taken from slides of each specimen by means of a Sony 
digital camera adapted to an Olympus CH30 microscope. 
The photos obtained by Soft Pinnacle Studio 9.4 with 
116.7X magnification were evaluated by Image Pro Plus 
analysis system (Media Cybernetics, Silver Spring, MD, 
USA Version 4.5.0.29 for Windows 1998/NT/2000). New 
bone formation was quantified and expressed as percentage 
of total bone (% BV/TV) in the area surrounding the implant. 
Statistical Analysis 
 Results are expressed as mean ± SEM. Statistical 
evaluation was carried out with nonparametric analysis of 
variance (Kruskal-Wallis). A value of p<0.05 was 
considered significant.  
RESULTS  
 The pore structure characterization of the foams used 
here was evaluated for control purposes. As previously 
reported [11, 15], the tested foams showed pore diameters of 
100–300 µm as examined by SEM (Fig. 1A and B). It is 
interesting to investigate the hydrated structure of the 
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hybrids because this reproduces the real condition when the 
foams are implanted. Thus, the pore structure of the hydrated 
foams was evaluated by 3-D confocal microscopy, which 
provides information about the bulk structure of the foam. 
We confirm that these hydrated foams exhibit 70% porosity 
(measured by the Archimedes method [11]) and an 
interconnected network of macroporous (Fig. 2A and B).  
 In the present study, we assessed the capacity of BG-
PVA scaffolds to retain osteostatin. It was found that the 
mean uptake of osteostatin by these scaffolds after 24 h of 
loading was 15%, equivalent to 0.2 µg peptide/g BG/PVA 
material. These loaded scaffolds released (as mean %) 80 % 
of loaded peptide to the surrounding medium within 1 h and 
virtually 100 % at 48 h (Fig. 3). We next examined the 
bioactivity conferred by osteostatin to BG-PVA scaffolds in 
vitro using osteoblastic cell cultures. We found that exposure 
to osteostatin loaded-BG-PVA scaffolds increased MC3T3-
E1 cell proliferation over that observed with the unloaded 
scaffolds. (Fig. 4). Moreover, these peptide-containing 
scaffolds significantly increased ALP activity and matrix 
mineralization in these cell cultures (Fig. 5A and B).  
 We also examined here the osteogenic action of 
osteostatin-coated BG-PVA scaffolds as implants into a non 
critical bone defect in the epiphysis of the rabbit femur. No 
clinical or biochemical alterations were detectable in rabbits 
bearing any of the tested implants with respect to healthy 
controls. By histological analysis, both experimental groups 
A and B showed new compact bone formation on the 
implant surface, with lamellae disposed around a haversian 
canal forming osteons-like structure. Trabecular bone with a 
reticular or laminar pattern was evident inside the scaffold, at 
1 or 3 months, respectively, surrounded by hematopoietic 
marrow. However, we observed differences in bone repair 
according to the type of implant (group A or B) within the 
bone defect.  
 In group-A rabbits, many inflammatory cells 
(macrophages and lymphocytes) were detected in the 
implant/newly formed bone interface at 1 month after 
implantation. Abundant scattered mineralized nodules were 
surrounded by inflammatory cells (filled with debris) within 
the implant at this time period (Fig. 6). However, 3 months 
after implantation, inflammatory cells were absent and 
 
 A B 
Fig. (1). SEM images of hybrid foams with 50% BG-50% PVA (A) and respective magnification showing interconnected porous structure 
(B).  
 
 A B 
Fig. (2). 3-D confocal microscopy images of hybrid foams with 50% BG-50% PVA, showing a surface (A) and inner (B) perspective. 
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replaced by new cortical bone with osteon-like structures on 
the implant surface (Fig. 7). Trabecular bone was formed 
toward the implant core, which was surrounded by osteoid 
lined with osteoblastic cells, with many debris particles (Fig. 
7).  
 At 1-month after implantation, rabbits from group B 
showed trabecular bone in the vicinity of cortical bone with 
osteon-like structures around the peptide-coated scaffold; 
inside the latter, many thin trabeculae in a reticular pattern 
and uncompletely mineralized- were observed (Fig. 8). 
These trabeculae showed a variable osteoid layer with small 
osteoblastic and lining cells on their surface (Fig. 8). Three 
months after implantation, an increase of newly formed bone 
was evident around the peptide-containing scaffold. 
Meanwhile, many thick trabeculae now invade the scaffold 
(mainly in its periphery), with abundant lining cells (Fig. 9). 
Foam debris was present around few trabeculae together 
with an immature bone marrow. No inflammatory 
component was present in the bone defect at any time period 
studied in rabbits with this peptide-loaded implant. 
Histomorphometric evaluation rendered BV/TV (%) values 
of: 54.2 and 59.3 (p<0.5%, by Mann Whitney test) for newly 
formed (cortical and cancellous) bone in rabbit groups A and 
B, respectively, at 3 months after implantation. 
 
Fig. (3). PTHrP (107-111) release profiles from PVA/BG scaffolds. Points to trace the curve are the means of three independent 
measurements per time period. The results, expressed as the mean ± SEM for each scaffold were the following:  
For 1h: 78.25 ±6.02; For 24 hs: 7.48 ± 3.74; For 48 hs: 2.63 ± 1.32; For 72 hs and so on: 100 ± 0. 
 
Fig. (4). MCT3T3-E1 cell proliferation (measured by Alamar blue assay) in the presence of PVA/BG loaded or not with osteostatin at day 4 
of culture.  
Results are mean ±SEM (n=4). (0.04266667 ± 4.6667E-0.6 for PVA/BG and 0.1053333 ± 0.00037267 for PVA/BG with PTHrp (107-
111)),**p<0.01.  
Characterization of Hybrid Bioactive Glass-polyvinyl Alcohol Scaffolds Containing The Open Biomedical Engineering Journal, 2014, Volume 8    25 
DISCUSSION 
 The present findings further confirm the validity of the 
sol-gel technique for producing hybrid scaffold foams with 
macroporous structure as implants for bone tissue 
engineering applications [14, 15, 21].  
 The BG-PVA scaffolds presented mechanical properties 
that are suitable for load bearing applications and for 
supporting 3-D cell growth in bone tissue engineering [1, 2]. 
The hybrids present resistance features that make them 
suitable for flexible manipulation to be used as implants to 
adapt to and fill bone defects [6, 15, 21]. Recent in vitro and 
in vivo reports using these hybrid scaffolds showed that 
osteoblasts maintain their viability in the presence of this 
type of material [15]. These scaffolds also allow 
mesenchymal cells to grow in 3D cultures [21]. 
 The in vitro and in vivo results obtained in this study 
further extend previous findings in other experimental 
systems [16-20, 22], and confirm the ability of osteostatin to 
confer osteogenic properties to materials of interest for tissue 
engineering applications. Osteostatin uptake by these BG-
PVA scaffolds was found to be poorer and its release to the 
medium was faster than that observed by other previously 
tested bioceramics [16, 17], supporting its efficacy even at 
very low doses delivered to the bone defect in vivo. 
 
 A B 
Fig. (5). (A) ALP activity in the presence of PVA/BG loaded or not with osteostatin in MC3T3-E1 cells at day 4 of culture. (B) 
Mineralization in the presence or absence of PVA/BG loaded or not with osteostatin at day 10 of MC3T3-E1 cell culture. Results are mean 
±SEM (n=3). **p<0.01. 
 
Fig. (6). Representative photomicrograph of a bone section embedded in methyl methacrylate and stained with Goldner´s, corresponding to a 
non-critical defect with peptide-unloaded scaffold at 1 month after implantation in the epiphysis of the distal rabbit femur. Black arrows 
denote inflammatory cells in the matrix surrounding the implant particles. Mineralized nodules (white arrows) were also present. 
Magnification, 700x.  
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 In our in vivo experimental model, we observed signs of 
inflammation around the implanted unloaded scaffold at one 
month, but this was resolved at 3 months. This early 
inflammation did not occur in the case of the peptide-loaded 
implant, supporting the notion that osteostatin may act as 
anti-inflammatory inhibitor as previously suggested [20]. On 
the other hand, the latter type of implant showed an 
increased bone forming activity, as depicted by many new 
trabeculae that were partly mineralized in the regenerating 
area around the implant, beginning at 1 month and more 
evident at 3 months after implantation.  
 In summary, PVA/BG hybrid scaffolds present a porous 
structure suitable to support osteoblast proliferation and 
differentiation. Our in vitro and in vivo findings indicate that 
osteostatin coating improves the osteogenic features of these 
scaffolds. Further studies are warranted to assess the 
usefulness of these biomaterials in tissue engineering 
strategies in vivo to promote bone regeneration.  
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Fig. (7). Representative photomicrographs of methyl methacrylate-
embedded bone sections stained with Goldner´s, corresponding to a 
non-critical defect with peptide-unloaded scaffold at 3 months after 
implantation in the epiphysis of the distal rabbit femur. Black arrow 
indicates cortical bone with Haversian´s system in the vicinity of 
the implant. Trabecular bone –of laminar type- was covered by 
osteoid (white arrow). Immature haematopoietic marrow and 
material debris (asterisk) were also observed. Magnification 40x 
(A); magnification, 63x (B). 
 
Fig. (8). Representative photomicrograph of a bone section 
embedded in methyl methacrylate and stained with Goldner´s, 
corresponding to a non-critical defect with osteostatin-loaded 
scaffold at 1 month after implantation in the epiphysis of the distal 
rabbit femur. Black arrows indicate abundant new cortical bone in 
the area around the implant. Many reticular mineralized (blue) and 
not mineralized (red) bone trabeculae were observed in this area. 
Magnification 117x.  
 
Fig. (9). Representative photomicrograph of a bone section 
embedded in methyl methacrylate and stained with Goldner´s, 
corresponding to a non-critical defect with osteostatin-loaded 
scaffold at 3 months after implantation in the epiphysis of the distal 
rabbit femur. At high magnification (467x), many new mineralized 
(blue) and not mineralized (red) trabeculae were observed, covered 
with osteoid and lining cells (black arrows). 
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